Cui Cui
Stock Analyst at Jefferies
(4.26)
# 1,357
Out of 4,417 analysts
32
Total ratings
56.7%
Success rate
27.7%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 0241 Alibaba Health Information Technology Limited | Maintained: Buy | $8.00 → $5.30 | $3.29 | +61.09% | 2 | May 19, 2026 | |
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $15.50 | $11.65 | +33.05% | 1 | Apr 3, 2026 | |
| HKG: 9966 Alphamab Oncology | Maintained: Buy | $9.60 | $7.26 | +32.23% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Maintained: Hold | $12.40 | $7.96 | +55.78% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $226.00 | $89.30 | +153.08% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $500.00 | $186.50 | +168.10% | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $300.00 → $520.00 | $413.60 | +25.73% | 3 | Aug 19, 2025 | |
| HKG: 6618 JD Health International Inc. | Maintained: Buy | $60.00 → $88.00 | $34.90 | +152.15% | 3 | Aug 15, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Sell | $5.00 | $6.90 | -27.54% | 1 | Jul 30, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $45.00 | $30.82 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 → $60.00 | $46.74 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175.00 → $87.40 | $127.00 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 | $76.65 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.00 | $2.08 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.80 | $6.69 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.00 | $16.69 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110.00 | $30.62 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 → $35.20 | $24.20 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.00 → $25.00 | $29.60 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $16.35 | n/a | 1 | Apr 22, 2020 |
Alibaba Health Information Technology Limited
May 19, 2026
Maintained: Buy
Price Target: $8.00 → $5.30
Current: $3.29
Upside: +61.09%
Genscript Biotech Corporation
Apr 3, 2026
Maintained: Buy
Price Target: $15.50
Current: $11.65
Upside: +33.05%
Alphamab Oncology
Mar 27, 2026
Maintained: Buy
Price Target: $9.60
Current: $7.26
Upside: +32.23%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Maintained: Hold
Price Target: $12.40
Current: $7.96
Upside: +55.78%
Akeso, Inc.
Oct 19, 2025
Maintained: Buy
Price Target: $226.00
Current: $89.30
Upside: +153.08%
Duality Biotherapeutics, Inc.
Oct 8, 2025
Maintained: Buy
Price Target: $500.00
Current: $186.50
Upside: +168.10%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Maintained: Buy
Price Target: $300.00 → $520.00
Current: $413.60
Upside: +25.73%
JD Health International Inc.
Aug 15, 2025
Maintained: Buy
Price Target: $60.00 → $88.00
Current: $34.90
Upside: +152.15%
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Maintained: Sell
Price Target: $5.00
Current: $6.90
Upside: -27.54%
WuXi Biologics (Cayman) Inc.
Mar 31, 2025
Maintained: Buy
Price Target: $45.00
Current: $30.82
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $41.00 → $60.00
Current: $46.74
Upside: n/a
Mar 21, 2025
Maintained: Buy
Price Target: $175.00 → $87.40
Current: $127.00
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $40.00
Current: $76.65
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $4.00
Current: $2.08
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $10.80
Current: $6.69
Upside: n/a
Nov 3, 2023
Maintained: Buy
Price Target: $26.00
Current: $16.69
Upside: n/a
Oct 31, 2023
Maintained: Buy
Price Target: $110.00
Current: $30.62
Upside: n/a
Oct 27, 2023
Maintained: Buy
Price Target: $40.00 → $35.20
Current: $24.20
Upside: n/a
Sep 4, 2023
Maintained: Buy
Price Target: $28.00 → $25.00
Current: $29.60
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $16.35
Upside: n/a